NCT02360345View on ClinicalTrials.gov

Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly

PHASE1CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2020

Study Completion Date

March 31, 2021

Conditions
Solid Tumours
Interventions
DRUG

ONX-0801

Trial Locations (1)

SM2 5PT

The Royal Marsden NHS Foundation Trust, Sutton

Sponsors

Collaborators (1)

Onyx Therapeutics, Inc.
All Listed Sponsors
collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

Onyx Therapeutics, Inc.

INDUSTRY

lead

Royal Marsden NHS Foundation Trust

OTHER